Free shipping on all orders over $ 500

 About 1 result found for searched term "1431957-73-1" (0.131 seconds)

Cat.No.  Name Target
M52642 FTISADTSK Metabolite/Endogenous Metabolite
FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM).



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.